Medscape Today Perspective

 
 
  • CV Risk Assessment: A Process, Not a Calculation   Tips on how to estimate, personalize, and reclassify patient risk in light of the new cholesterol guidelines. Dr Blaha walks through a typical patient case with guideline writer Dr Lloyd-Jones
  • Kerr, Tannock on the 'Triangle of Mediocrity' Holding Oncology Back   With nearly 75 years of oncology experience between them, Drs Kerr and Tannock take aim at the pitfalls of precision medicine and the 'triangle of mediocrity' among academic medicine, pharma companies, and the FDA.
  • Conflicts of Interest: Is Disclosure Enough?   Disclosures and conflicts of interest: Dr George Lundberg discusses recent issues in American medicine.
  • Malpractice Case: Staff Activities That Could Lead to Problems Physicians can be challenged to know in detail all of the activities occurring within a busy medical practice. But an occasional check on regular procedures is a good place to start.
  • AHA 2018Think You're Immune From Bias? Think Again John Mandrola, MD, is intrigued by two studies at AHA that track the cognitive and financial biases that may influence what physicians do in practice and how they write and read research papers.
  • A 5-Week-Old Boy With Vomiting: USMLE Question A 5-week-old infant boy is brought to the emergency department because of worsening nonbilious projectile vomiting over the past week. What laboratory finding is most likely?
  • Supraglottic Airway Device or Tracheal Intubation in OHCA? Is a supraglottic airway device superior to tracheal intubation as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest?
  • AHA 2018What's Needed After AHA 2018? ACTION A sparsely attended session on social determinants of health sounded very familiar to Melissa Walton-Shirley, MD. So if we know what to do to improve CV health, why haven’t we done it yet?
  • When Art Talks: Expressions of Clinician Well-Being Medscape presents some of the most evocative visual artworks, created by clinicians, students, patients, and loved ones, from the Expressions of Clinician Well-Being art exhibition.
  • What 'Well-Being' Means to Clinicians Can art provide a key to promoting dialogue around critical levels of burnout and rates of suicide among clinicians?
  • VITAL Results for Vitamin D and Omega-3s   The largest prospective randomized trial of vitamin D and omega-3 supplementation provides much-needed information.
  • CV Risk: Can Prescription Omega-3 REDUCE-IT?   Low-dose omega-3 flopped for CV risk reduction. Melissa Walton-Shirley, MD, dissects the REDUCE-IT trial from AHA, which used high-dose prescription EPA, with principal investigator, Deepak Bhatt, MD.
  • Nurse Leadership: Breaking the Code Catherine Burger tells nurses what it takes to become a nurse leader and how to land a nurse leadership position.
  • Vitamin D Deficiency Elevates Colorectal Cancer Risk   Dr David Johnson on why we should consider vitamin D supplementation beyond its benefits for bone health.
  • Eating in the Raw: Are Raw Food Devotees Right or at Risk? The centuries-old raw food movement is experiencing a resurgence. Is this diet ancient wisdom or modern folly?
  • 'Shocking' Results With Minimally Invasive Hysterectomy   The surprising results of two new studies prompt a warning from Dr Maurie Markman that minimally invasive radical hysterectomy should not be considered standard of care for early cervical cancer.
  • First-Ever Pediatric Concussion Guidelines: Real-Life Cases Are you up on the new guidelines for evaluating kids with possible mild traumatic brain injury? These cases illustrate key points to be aware of, wherever you encounter these children.
  • Managing Gout as a Systemic Disease   A study suggests that to reduce morbidity and mortality from hyperuricemia, it must be managed as a chronic disease.
  • Antibiotics for Everyone? Is it possible to keep patients happy while practicing antimicrobial stewardship?
  • For the Good of Your Patients, Use SGLT2 Inhibitors   Don't let mixed messages about SGLT2 inhibitors and reports of adverse effects deter you from prescribing these drugs, says Per-Henrik Groop.